Details of the Drug

General Information of Drug (ID: DM2A5IH)

Drug Name
DNA-C
Indication
Disease Entry ICD 11 Status REF
Human immunodeficiency virus infection 1C62 Phase 1/2 [1]
Cross-matching ID
TTD ID
D0XJ5I

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)